(Total Views: 638)
Posted On: 10/26/2020 10:41:07 AM
Post# of 155686
Re: Rubraquercus #63216
Rubraquercus,
Cytodyn has made reasonable steps to secure supply. The issues over the next six months is EUA/approval so that leronlimab can be sold and the ability to pay for that supply and ongoing operations.
Funding/potential funding sources:
OWS/ BARDA
MHRA/EAMS
Additional loans
Stock sales
I don’t concur that management is a joke, but certainly there have been missteps.
MHRA, Philippines, continued efforts to complete Covid enrollment are positive.
Patience required. Plenty of opportunity for both traders and investors here. I’ll remain in the latter camp.
Cytodyn has made reasonable steps to secure supply. The issues over the next six months is EUA/approval so that leronlimab can be sold and the ability to pay for that supply and ongoing operations.
Funding/potential funding sources:
OWS/ BARDA
MHRA/EAMS
Additional loans
Stock sales
I don’t concur that management is a joke, but certainly there have been missteps.
MHRA, Philippines, continued efforts to complete Covid enrollment are positive.
Patience required. Plenty of opportunity for both traders and investors here. I’ll remain in the latter camp.
(9)
(0)
